ArticleJournal of cancer research and clinical oncology2025

Docetaxel rechallenge in HER2-negative metastatic breast cancer: a real-world study of previously discontinued patients for non-progression reasons.

Hui-Ai Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.